Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.
David W Eyre;
Nicholas D Sanderson;
Emily Lord;
Natasha Regisford-Reimmer;
Kevin Chau;
Leanne Barker;
Markus Morgan;
Robert Newnham;
Daniel Golparian;
Magnus Unemo;
+7 more...
Derrick W Crook;
Tim Ea Peto;
Gwenda Hughes 
;
Michelle J Cole;
Helen Fifer;
Anne Edwards;
Monique I Andersson;
(2018)
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.
Eurosurveillance, 23 (27).
pp. 2-7.
ISSN 1560-7917
DOI: 10.2807/1560-7917.ES.2018.23.27.1800323
;
Michelle J Cole;
Helen Fifer;
Anne Edwards;
Monique I Andersson;
(2018)
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.
Eurosurveillance, 23 (27).
pp. 2-7.
ISSN 1560-7917
DOI: 10.2807/1560-7917.ES.2018.23.27.1800323
We describe a gonorrhoea case with combined high-level azithromycin resistance and ceftriaxone resistance. In February 2018, a heterosexual male was diagnosed with gonorrhoea in the United Kingdom following sexual intercourse with a locally resident female in Thailand and failed treatment with ceftriaxone plus doxycycline and subsequently spectinomycin. Resistance arose from two mechanisms combining for the first time in a genetic background similar to a commonly circulating strain. Urgent action is essential to prevent further spread.
-
picture_as_pdf - Eyre_etal_2018_Gonorrhoea-treatment-failure-caused-by-a.pdf
-
subject - Published Version
-
- Available under Creative Commons: 3.0
Downloads